1 - 10 of 38 articles
Patients A. atients are being recruited for a three-year, 12-center, National Eye Institute-supported clinical trial of vitamin C in treating severe, caustic eye burns.
Volunteers will be randomized into groups treated either with ascorbic acid or with a placebo, according to Roswell R. Pfister,...
Fifteen minutes may mean the difference between recovery and irreparable damage from retinal ischemia.
Studies with 32 rhesus monkeys in Iowa City indicate that the retina can tolerate central artery occlusion for up to 90 minutes with full recovery. However, say the University of Iowa College...
Growth of new blood vessels in the eye's anterior chamber can obstruct aqueous humor flow, raising intraocular pressure from about 14 mm Hg to as much as 90 mm Hg. But a research group has developed a valve implant that is demonstrating "encouraging" results in relieving this neovascular...
Human corneal endothelium heals reluctantly, which can be troublesome following transplantation, other surgery, or injury. But experiments suggest that improved, more rapid healing may be induced extraneously.
Virginia Lee Weimar, PhD, told a Research to Prevent Blindness seminar in Los Angeles...
Some new pieces of information are falling into place in the senile cataract puzzle. There is hope, says a New York researcher, that methods eventually may be developed to retard or prevent this process.
In a report to a Research to Prevent Blindness seminar in Los Angeles, Abraham Spector, PhD,...
The monkey—"the only animal with a macula identical to that of humans"—may soon start providing some information on the natural course of the mysterious human ophthalmologic condition that is thought to be ocular histoplasmosis.
According to Ronald E. Smith, MD, associate professor of...
Controversy is simmering over whether enucleation, which has been the treatment of choice for uveal melanomas for more than a century, may actually accelerate dissemination of tumor cells from this cancer. In one of the latest developments, Washingtonton, DC, researchers—after a retrospective...
In a recent JAMA MEDICAL NEWS story on premarket approval of class III medical devices by the Food and Drug Administration (242:2749-2753, 1979), the name of one device was incorrectly spelled and the manufacturer's name was incorrectly given.
The biochemical test to detect Neisseria gonorrhoeae...
To the Editor.—
We do not share the enthusiasm of Post and colleagues (242:158, 1979) for multiple "microbiopsies" in the diagnosis of prolactin (PRL) adenomas nor, indeed, for any other type of pituitary adenoma.
It is our experience after evaluating the biopsy specimens of more than 100...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.